Cargando…
Modulating effect of Xuanfei Baidu granule on host metabolism and gut microbiome in rats
Xuanfei Baidu granule (XFBD) is a recommended patented drug for the prevention and treatment of Corona Virus Disease 2019 (COVID-19), which is approved by the National Medical Products Administration. XFBD suppresses the over-activated immune response caused by inflammatory factor storms in COVID-19...
Autores principales: | He, Qiaoyu, Shi, Yumeng, Xing, Hong, Tang, Qian, Liu, Jing, Li, Chunxia, Zhang, Han, Zhang, Boli, Zhang, Junhua, Chen, Xiaopeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486314/ https://www.ncbi.nlm.nih.gov/pubmed/36147334 http://dx.doi.org/10.3389/fphar.2022.922642 |
Ejemplares similares
-
Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2021) -
Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2022) -
Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics
por: Xiong, Li, et al.
Publicado: (2022) -
Efficacy and safety of Xuanfei Baidu granules for treating COVID-19: A protocol for systematic review and meta-analysis
por: Zhao, Jisen, et al.
Publicado: (2021) -
Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway
por: Wang, Yuying, et al.
Publicado: (2022)